Table 2 Adverse events during follow up.
Adverse event | Number of cases (%) | Level of severity | Degree of seriousness | Outcome | Relation to the application |
---|---|---|---|---|---|
Treatment-related pain | 4 (50.0) | Moderate | Non-serious | Recovered | Not related |
Fever | 3 (37.5) | Moderate | Non-serious | Recovered | Might be related |
Back pain | 2 (25.0) | Moderate | Non-serious | Recovered | Not related |
Nausea | 2 (25.0) | Moderate | Non-serious | Recovered | Might be related |
Insomnia | 1 (12.5) | Moderate | Non-serious | Recovered | Not related |
Itchiness | 1 (12.5) | Moderate | Non-serious | Recovered | Not related |
Joint pain | 7 (87.5) | Mild | Non-serious | Recovered | Not related |
CRP elevation | 5 (62.5) | Mild | Non-serious | Recovered | Not related |
Joint effusion | 3 (37.5) | Mild | Non-serious | Recovered | Not related |
Postoperative anemia | 2 (25.0) | Mild | Non-serious | Recovered | Might be related |
Amylase elevation | 2 (25.0) | Mild | Non-serious | Recovered | Not related |
CPK elevation | 2 (25.0) | Mild | Non-serious | Recovered | Not related |
ALP elevation | 2 (25.0) | Mild | Non-serious | Recovered | Might be related |
Swelling | 1 (12.5) | Mild | Non-serious | Recovered | Not related |
ALT elevation | 1 (12.5) | Mild | Non-serious | Recovered | Not related |
AST elevation | 1 (12.5) | Mild | Non-serious | Recovered | Not related |
Eosinophil elevation | 1 (12.5) | Mild | Non-serious | Recovered | Not related |
Hypersensitive | 1 (12.5) | Mild | Non-serious | Recovered | Not related |
Hypertension | 1 (12.5) | Mild | Non-serious | Recovered | Not related |